Very concerning when a top-level domain registry disables your domain a month after accepting renewal payment, and then does not respond to any support tickets or accept phone calls. Anyone else having trouble with @COCCA_Council ? (not bionicwookiee, another domain)
I missed the screenshot, but there was a very unfortunate association of body-type image with T2D in Jorgen Rungby's talk about Neuroprotective mechanisms. I almost spat my drink over my screen. #dedoc#EASD2023
A presentation comparing results from "1st-generation and 2nd-generation commercial AID systems". While I wasn't surprised to see 670G in the 1st-gen bracket, it was interesting to see CIQ as the "2nd-gen" example. I wonder how many "generations" are labelled! #EASD2023#Dedoc
Off-hand comment by Tim Heise that "of course cardiovascular outcomes are more of an issue for Type 2 [than Type 1]". This was in the Q&A after a talk about an experimental basal insulin. REALLY? I hope no-one's assuming CV outcomes are NOT important for T1! #dedoc#EASD2023
Our #dedoc° voices are bringing more than 900 years of lived experience with #diabetes to #EASD2023.
Keep an eye on our Instagram stories and follow the hashtag #dedoc° here on Twitter — our #dedoc° voices will be sharing conference highlights, learnings and much more next week!
Good to see the updated TIR recommendations for clinical trials presented. I'll have to update my CGM reports to include some of the new metrics. #ADA2023#dedoc@dedocORG
Good to see data being published about fasting with T1D during Ramadan (using a large dataset gathered in KSA). Conclusion of the paper is that automated insulin delivery systems are the safest and most effective solution. #ADA2023#dedocvoices#dedoc
Sixth (last) finalist in the ADA Innovation Challenge: Minutia's stem-cell-derived insulin-generating cells (small device in the forearm). The cells provide real-time data on their viability/etc and apparently don't need immunotherapy. #ADA2023#dedocvoices#dedoc
Fifth finalist in the ADA Innovation Challenge: the Go-Pen. An affordable insulin pen for the developing world. Simple technology, with the potential for massive health impact by replacing syringes. #ADA2023#dedocvoices#dedoc